Is Combining an Anticholinergic with a Cholinesterase Inhibitor a Good Strategy for High-Level CNS Cholinesterase Inhibition?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is Combining an Anticholinergic with a Cholinesterase Inhibitor a Good Strategy for High-Level CNS Cholinesterase Inhibition?

Published:2019-10-15 Issue:4 Volume:71 Page:1099-1103
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Moss Donald E.¹

Affiliation:

1. Department of Psychology, University of Texas at El Paso, El Paso, TX, USA

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference51 articles.

1. The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease;Hampel;Brain,2018

2. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer’s disease?;Hashimoto;Am J Psychiatry,2005

3. The potentially protective effect of donepezil in Alzheimer’s disease;Ishiwata;Dement Geriatr Cogn Disord,2014

4. Effects of donepezil on brain morphometric and metabolic changes in patients with Alzheimer’s disease: A DARTEL-based VBM and1H-MRS;Moon;Magn Reson Imaging,2016

5. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer’s disease;Krishnan;Am J Psychiatry,2003

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the preventive effects of neostigmine plus atropine on post-dural puncture headache;Advanced Biomedical Research;2023

2. Optimizing treatment for older adults with depression;Therapeutic Advances in Psychopharmacology;2023-01

3. Amyloid β, Lipid Metabolism, Basal Cholinergic System, and Therapeutics in Alzheimer’s Disease;International Journal of Molecular Sciences;2022-10-11

4. Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer’s Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction;Current Alzheimer Research;2021-11-29

5. Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer’s disease;Expert Opinion on Drug Metabolism & Toxicology;2020-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3